NCT02049203View on ClinicalTrials.gov

Safety of Ataciguat in Patients With Moderate Calcific Aortic Valve Stenosis

PHASE1CompletedINTERVENTIONAL

Enrollment

44

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions

Aortic Valve Stenosis

Interventions

DRUG

Ataciguat

DRUG

Placebo

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Collaborators (1)

Sanofi-Synthelabo

All Listed Sponsors

collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

collaborator

Sanofi-Synthelabo

INDUSTRY

collaborator

National Center for Research Resources (NCRR)

NIH

lead

Jordan D. Miller, Ph.D.

OTHER